Replay launches big DNA HSV gene therapy company, Telaria, focused on rare skin diseases Replay launches big DNA HSV gene therapy company, Telaria, focused on rare skin diseases Second product company using Replay’s next-generation high payload capacity HSV delivery vector developed at...

Bragar Eagel & Squire, P.C. Announces that it is Investigating the Boards of Directors of Mobile Mini, Forty Seven, Cincinnati Bell, and Telaria on behalf of Stockholders and Encourages Investors to Contact the Firm NEW YORK, March 02, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces to investors that it is investigating potential claims on behalf of stockholders of Mobile Mini, Inc. (NASDAQ:...